Historique
![Leading the next CBD wave - Safety and efficacy [Viewpoint]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_82560.webp?v=1771308787)
Article de Périodique
Leading the next CBD wave - Safety and efficacy [Viewpoint] (2020)
Auteur(s) :
HURD, Y. L.
Année
2020
Page(s) :
341-342
Langue(s) :
Anglais
Refs biblio. :
7
Domaine :
Autres substances / Other substances
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
CANNABINOIDES
;
USAGE THERAPEUTIQUE
;
SECURITE SANITAIRE
;
EFFICACITE
;
PHENOMENE EMERGENT
;
ETUDE CLINIQUE
Résumé :
Cannabidiol (CBD), a phytocannabinoid with potential medicinal properties, has recently hit all levels of society with tidal wave force that very few saw coming. After being virtually unknown by most people not even a decade ago, CBD is now in the general lexicon with numerous companies riding the CBD wave: more than 1000 products are being sold through the internet, dispensaries, pharmacies, large national retail stores, boutique shops, and local bodegas. This, along with extensive media coverage, has made CBD a household name and spawned an international business with an estimated market value of more than $60 billion within the next few years. [Extract]
Affiliation :
Addiction Institute, Mount Sinai Behavioral Health System, Icahn School of Medicine at Mount Sinai, New York, NY, USA